Eine große Zahl von VC Investitionen im Life Science Bereich und deren Innovation sind implizit Investitionen in personalisierte Medizin oder Precision Medicine. Das können Beteiligungen an einer …
News
NOXXON PHARMA secures a private placement of 1 million Euro and additional financing of up to 10 million Euro through convertible notes with share subscription warrants attached to finance further clinical development of NOX-A12
Berlin, Germany, May 2, 2017 - NOXXON Pharma N.V. (Alternext Paris: ALNOX), a biotechnology company whose core focus is on improving cancer treatment by targeting the tumor microenvironment, today …
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
$960 million deal will enhance Lilly’s existing pain management portfolio for migraine; adds potential near-term launch to its late-state pipeline INDIANAPOLIS, IN and CAMBRIDGE, MA, January 18, …
leon Appoints Pharma Expert Michael Mehler as Chief Executive Officer
leon nanodrugs GmbH appoints pharma expert Michael Mehler, Sc.D. as new CEO of the Munich based company and its U.S. subsidiary leon-nanodrugs Inc, effective today. He succeeds Dr. Theron (Ted) …
Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS
Schlieren, Switzerland, and Munich, Germany, December 07, 2016 / B3C newswire / -- Neurimmune and TVM Capital Life Science’s latest fund, TVM Life Science Ventures VII, today announced their …
Pfizer Ventures and TVM Life Science Ventures VII Announce Additional Investment in Ixchelsis Ltd.
London, UK, December 05, 2016 / -- Pfizer Venture Investments (PVI) and TVM Life Science Ventures VII today announced that they are making an additional $12M investment in Ixchelsis Ltd, a start-up …